An in vitro bovine cellular model for human schlemm’s canal endothelial cells and their response to tgfβ treatment

Keyphrases

• Endothelial Cells 100%
• Schlemm's Canal 100%
• Cellular Model 100%
• Plexus 87%
• Glaucoma 25%
• Upstream Regulator 25%
• Ingenuity Pathway Analysis 25%
• Transforming Growth factor-β2 (TGF-β2) 25%
• Droplet Digital PCR (ddPCR) 25%
• Quantitative PCR 12%
• Differentially Expressed Genes 12%
• Cellular Response 12%
• CYP1B1 12%
• Endothelial Markers 12%
• Nonglaucomatous 12%
• Bone Morphogenetic Protein 4 (BMP4) 12%
• Limited Availability 12%
• Expression Profiling 12%
• Von Willebrand Factor 12%
• Puromycin 12%
• Smad2 12%
• Glaucomatous 12%
• Trabecular Meshwork 12%
• Software Application 12%
• Translational Relevance 12%
• Positive Expression 12%
• Functional Pathways 12%
• TGFBR1 12%
• Outflow Facility 12%
• Vascular Endothelial Cadherin (VE-cadherin) 12%
• Mechanoresponsive 12%
• Bovine Eye 12%
• Cobblestoning 12%
• In Vitro Cellular Model 12%

Medicine and Dentistry

• In Vitro 100%
• Endothelial Cell 100%
• Cellular Model 100%
• Schlemm's Canal 100%
• Glaucoma 25%
• Droplet Digital Polymerase Chain Reaction 25%
• Transforming Growth Factor Beta2 25%
• Real Time Polymerase Chain Reaction 12%
• Von Willebrand Factor 12%
• Puromycin 12%
• Trabecular Meshwork 12%
• CYP1B1 12%
• Bone Morphogenetic Protein 4 12%
• Vascular Endothelial Cadherin 12%

Biochemistry, Genetics and Molecular Biology

• TGF Beta 2 100%
• Droplet Digital Polymerase Chain Reaction 100%
• Real-Time Polymerase Chain Reaction 50%
• Puromycin 50%
• Von Willebrand Factor 50%
• Bone Morphogenetic Protein 4 50%
• VE-cadherin 50%
• CYP1B1 50%
• Differentially Expressed Gene 50%